EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹9.04 Cr | ₹41 Cr | ₹-60 Cr | ₹-73 Cr | ₹-108 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of EMCURE PHARMACEUTICALS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹9.04 Cr |
| Mar2024 | ₹41 Cr |
| Mar2023 | ₹-60 Cr |
| Mar2022 | ₹-73 Cr |
| Mar2021 | ₹-108 Cr |
How is Deferred Tax Assets / Liabilities of EMCURE PHARMACEUTICALS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹9.04 Cr | -77.74 | |
| Mar2024 | ₹41 Cr | Positive | |
| Mar2023 | ₹-60 Cr | Negative | |
| Mar2022 | ₹-73 Cr | Negative | |
| Mar2021 | ₹-108 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹28,224.8 Cr | -3.7% | -5.4% | 20.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,431.0 Cr | -0.4% | -0.1% | -2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,772.0 Cr | 0.9% | -3% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,884.0 Cr | 2% | 1.7% | 25.2% | Stock Analytics | |
| CIPLA | ₹107,503.0 Cr | -0.9% | -7.2% | -9.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,798.0 Cr | -0.6% | 6.8% | 2.7% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | -3.7% |
-5.4% |
20.6% |
| SENSEX | -1.1% |
-1.2% |
5.9% |
You may also like the below Video Courses